SPRO
Spero Therapeutics, Inc. · Healthcare
CEO and President Sath Shukla sold $108K of Spero Therapeutics, Inc.
Sold$107,719
$1.42Price
75,994Shares
−6%Stake
What SPRO did after the filing
- The stock from Mon, Feb 5 close, $1.44
- +23.6%
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Mar 19 close.
Traded Fri, Feb 2. Filed Mon, Feb 5, 3:40 PM ET, during the session. Returns use the Feb 5 close and the Mar 19 close. Not investment advice.